Call for less regulation in German healthcare sector
This article was originally published in Clinica
Executive Summary
Germany's industry federation, the BDI, has urged that market forces be allowed to have due influence over the national healthcare products sector. Speaking at the annual general meeting of medtech industry association Spectaris, in Stuttgart last week, BDI deputy-president Friedhelm Loh said: "German can only be a worldwide leader in healthcare innovations when there is free pricing that promotes competition for such innovative products." He added that only then will it be possible for companies to invest in relatively costly and high-risk products.
You may also be interested in...
ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
FDA Sets New Restrictions For Authorized N95 Decontamination Systems
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Biden Signs COVID-19 Relief EO To Expand And Accelerate Testing, Fill PPE Shortages
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.
Need a specific report? 1000+ reports available
Buy Reports